FLT3 and acute myeloid leukemia: Also, in our cohort of patients ABCB1 expression level was not a predictor of resistant disease, but we have found association between ABCB1+ status and the absence of NPM1 and FLT3-ITD mutations, molecular markers with an already established prognostic significance in AML-NK.